Despite improvements over the last two decades in the inclusion of women as participants in clinical trials, women are still underrepresented in trials for some therapeutic areas that impact this population the greatest, such as cardiovascular disease. Join Membership Committee co-chairs, Gigi McMillan and Sharon Freitag, for a discussion on the inclusion of women as participants in clinical trials.
This conversation will be facilitated using the
discussion guide from October’s issue of Research Ethics Digest on the following article:
Barbara E. Bierer, Laura G. Meloney, Strategies to optimize inclusion of women in multi-national clinical trials, Contemporary Clinical Trials, Volume 117, 2022, 106770, ISSN 1551-7144,https://doi.org/10.1016/j.cct.2022.106770.(https://www.sciencedirect.com/science/article/pii/S1551714422000969)This event is free and open to all PRIM&R members.